Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/20/2014WO2014010900A9 Composition for preventing or treating hair loss or promoting hair growth comprising secoiridoid glucoside derivatives
02/20/2014WO2014008379A3 Diamine and meglumine salt forms of fatty acids
02/20/2014WO2014008361A3 Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
02/20/2014WO2014007972A9 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinphrine
02/20/2014WO2014007549A3 Composition for preventing or treating colitis comprising s-allyl-l-cysteine as active ingredient, and medical preparation comprising same
02/20/2014WO2014005013A3 Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
02/20/2014WO2014004761A3 Plant parts and extracts having anticoccidial activity
02/20/2014WO2014004674A3 Combination treatment of abt-450 and ritonavir and e.g. abt-072 and/or abt-333|for use in treating hcv
02/20/2014WO2014002114A3 Process for preparation of saxagliptin and hydrates thereof
02/20/2014WO2014002101A8 Lim kinase inhibitors
02/20/2014WO2014002011A9 Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof
02/20/2014WO2013188848A3 Antiviral compounds and methods of use
02/20/2014WO2013188792A3 Neuroactive steroids, compositions, and uses thereof
02/20/2014WO2013186726A3 Multicomponent crystals comprising dasatinib and selected cocrystal formers
02/20/2014WO2013179298A3 A process for preparation of phenyl carbamate derivative and polymorphic forms thereof
02/20/2014WO2013179253A8 Fixed dose combination comprising nsaid and steroidal anti-inflammatory agent for treating post operative ocular inflammation
02/20/2014WO2013175376A3 Compositions and methods for the treatment of local pain
02/20/2014WO2013175359A3 Compositions and methods for the treatment of multiple sclerosis
02/20/2014WO2013173417A3 Glucokinase activator compositions for the treatment of diabetes
02/20/2014WO2013151665A3 Modified polynucleotides for the production of proteins associated with human disease
02/20/2014WO2013149996A9 Substituted tricyclic compounds with activity towards ep1 receptors
02/20/2014WO2013100567A8 Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain
02/20/2014WO2013100566A8 Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
02/20/2014WO2013005094A8 Acid addition salt of donepezil and pharmaceutical composition thereof
02/20/2014WO2012156820A9 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism
02/20/2014WO2012145617A9 Aminopyrimidine kinase inhibitors
02/20/2014WO2012109545A3 Method for obtaining a lipid-containing composition from microbial biomass
02/20/2014WO2009021750A3 Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy
02/20/2014US20140052081 Donepezil transdermal patch
02/20/2014US20140051769 Method and composition for improving the health of young monogastric mammals
02/20/2014US20140051768 Method of treating diseases that respond to therapy by dopamine or dopamine agonists
02/20/2014US20140051767 Parenteral formulations of rasagiline
02/20/2014US20140051765 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
02/20/2014US20140051763 Methods of treating frontal temporal dementia (ftd) with comprising administering metal chelators to the upper one-third of the nasal cavity
02/20/2014US20140051761 Katp antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant
02/20/2014US20140051760 Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties
02/20/2014US20140051759 Bipolar trans carotenoid salts and their uses
02/20/2014US20140051758 High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof
02/20/2014US20140051757 Therapeutical method for the treatment of the leber optic neuropathy
02/20/2014US20140051756 Method for preventing or treating arrhythmia, method for preventing or treating atrial fibrillation, model of sustained atrial fibrillation, method for producing the model, and method for screening for atrial fibrillation inhibitor
02/20/2014US20140051755 Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
02/20/2014US20140051754 Zinc n-acetyl taurinate for the treatment of prostate cancer
02/20/2014US20140051753 Phenylcarbamate compound and muscle relaxant containing the same
02/20/2014US20140051752 Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol
02/20/2014US20140051750 Low-dose doxepin for treatment of sleep disorders in elderly patients
02/20/2014US20140051749 Solid forms of an antiviral compound
02/20/2014US20140051745 Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
02/20/2014US20140051744 Markers For Assessing the Susceptibility of Cancer to Survivin-Targeting miRNA Treatment
02/20/2014US20140051743 Regulator, pharmaceutical composition encompassing the regulator and application thereof
02/20/2014US20140051742 Lipophilic Curcumin Analogs And Methods Of Inhibiting HIV-1, Treating Latent HIV In The Brain, And Preventing HIV-Mediated Cognitive Decline And HIV Dementia
02/20/2014US20140051740 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
02/20/2014US20140051738 Oxymetazoline For The Treatment Of Ano-Rectal Disorders
02/20/2014US20140051737 Methods for the treatment and diagnostic of pulmonary arterial hypertension
02/20/2014US20140051734 Treatment of Type 2 Diabetes With a Combination of DPIV Inhibitor and Metformin or Thiazolidinedione
02/20/2014US20140051733 Febuxostat pharmaceutical compositions
02/20/2014US20140051731 Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
02/20/2014US20140051730 Therapeutic use of dimiracetam to prevent the hand and foot syndrome caused by sorafenib
02/20/2014US20140051729 Compositions and methods for treating degenerative muscle conditions
02/20/2014US20140051726 5-HT4 Receptor Agonist as a Prokinetic Agent
02/20/2014US20140051725 Method For Increasing The Activity Of Lysosomal Enzymes
02/20/2014US20140051723 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
02/20/2014US20140051718 Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan
02/20/2014US20140051717 Methods and systems for treatment of migraines and other indications
02/20/2014US20140051716 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
02/20/2014US20140051714 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
02/20/2014US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1
02/20/2014US20140051708 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
02/20/2014US20140051707 Treatment of erectile dysfunction and other indications
02/20/2014US20140051704 Hypotensive Lipid And Timolol Compositions And Methods Of Using Same
02/20/2014US20140051702 Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis
02/20/2014US20140051700 Small-molecule agonists for type-2 orexin receptor
02/20/2014US20140051697 Compounds for treating respiratory syncytial virus infections
02/20/2014US20140051696 Therapies for treating cancer
02/20/2014US20140051693 Treatment for cerebral palsy impaired speech in children
02/20/2014US20140051692 Inhibitors of Human Immunodeficiency Virus Replication
02/20/2014US20140051690 Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant
02/20/2014US20140051689 Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections
02/20/2014US20140051685 Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity or prediabetes
02/20/2014US20140051678 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
02/20/2014US20140051677 Novel compound useful for the treatment of degenerative and inflammatory diseases
02/20/2014US20140051676 Triazine-oxadiazoles
02/20/2014US20140051675 Modulators of cellular adhesion
02/20/2014US20140051674 New compounds
02/20/2014US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions
02/20/2014US20140051671 Pharmaceutical compositions
02/20/2014US20140051670 Compositions Containing Moxifloxacin for Treating Otic Infections
02/20/2014US20140051669 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
02/20/2014US20140051666 Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
02/20/2014US20140051665 Prostate cancer therapy with hsp90 inhibitory compounds
02/20/2014US20140051664 Combination therapy of hsp90 inhibitory compounds with radiotherapy
02/20/2014US20140051662 Treatment of multiple myeloma with masitinib
02/20/2014US20140051658 Chia Seed Mucilage As soothing Agent in Personal Care Products
02/20/2014US20140051656 Antiviral compounds
02/20/2014US20140051655 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
02/20/2014US20140051653 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
02/20/2014US20140051652 Treatment for Migraine Headache
02/20/2014US20140051650 Vaginal compositions based on alkyl polyglucosides
02/20/2014US20140051649 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
02/20/2014US20140051648 Inhibitor of Sodium-Dependent Glucose Transport Protein and Preparation Method Therefor and Use Thereof
02/20/2014US20140051646 Cell penetrating peptides
1 ... 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 ... 7860